c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D

Leukemia Research

Volumn 33, Issue 10, 2009, Pages 1372-1378

  Chen Deutsch, Xiangwen ^a   Garay, Edward ^a   Zhang, Jing ^a   Harrison, Jonathan S ^b   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

AML; Differentiation; Drug resistance; JNK pathway; Nuclear localization; Vitamin D

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; CALCITRIOL; CARNOSIC ACID; CCAAT ENHANCER BINDING PROTEIN BETA; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEIN C JUN; PROTEIN P46; PROTEIN P54; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUNB;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER RESISTANCE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; CELL DIFFERENTIATION; CELL DIVISION; DITERPENES, ABIETANE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; IMIDAZOLES; LEUKEMIA, MYELOID, ACUTE; MITOGEN-ACTIVATED PROTEIN KINASE 9; PLANT EXTRACTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-JUN; PYRIDINES; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TRETINOIN;

EID: 67649373338     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.003     Document Type: Article

References (41)

1. Lian J.B., Javed A., Zaidi S.K., Lengner C., Montecino M., van Wijnen A.J., et al. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14 (2004) 1-41
2. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11 (1999) 299-308
3. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7 (2006) 885-896
4. Wang X., and Studzinski G.P. Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module. J Cell Physiol 209 (2006) 253-260
5. Ji Y., and Studzinski G.P. Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res 64 (2004) 370-377
6. Wang X., and Studzinski G.P. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem 82 (2001) 68-77
7. 2 vitamin D3 on signal transduction systems in colonic cells. Steroids 64 (1999) 137-142
8. Bikle D.D., Ng D., Tu C.L., Oda Y., and Xie Z. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 177 (2001) 161-171
9. Xie Z., and Bikle D.D. The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J Biol Chem 282 (2007) 8695-8703
10. Marcinkowska E., and Kutner A. Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells. Acta Biochim Pol 49 (2002) 393-406
11. Hmama Z., Nandan D., Sly L., Knutson K.L., Herrera-Velit P., and Reiner N.E. 1Alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med 190 (1999) 1583-1594
12. Zhang Y., Zhang J., and Studzinski G.P. AKT pathway is activated by 1,25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells. Cell Cycle 5 (2006) 447-451
13. Wang Q., Wang X., and Studzinski G.P. Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3. J Cell Biochem 89 (2003) 1087-1101
14. Ji Y., Kutner A., Verstuyf A., Verlinden L., and Studzinski G.P. Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle 1 (2002) 410-415
15. Hughes P.J., and Brown G. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway. J Cell Biochem 98 (2006) 590-617
16. Beno D.W., Brady L.M., Bissonnette M., and Davis B.H. Protein kinase C and mitogen-activated protein kinase are required for 1,25-dihydroxyvitamin D3-stimulated Egr induction. J Biol Chem 270 (1995) 3642-3647
17. Narayanan R., Sepulveda V.A., Falzon M., and Weigel N.L. The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem 279 (2004) 47298-47310
18. Marcinkowska E. Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res 21 (2001) 499-504
19. Aubert J., Belmonte N., and Dani C. Role of pathways for signal transducers and activators of transcription, and mitogen-activated protein kinase in adipocyte differentiation. Cell Mol Life Sci 56 (1999) 538-542
20. Matsumura I., and Kanakura Y. Molecular control of megakaryopoiesis and thrombopoiesis. Int J Hematol 75 (2002) 473-483
21. Frebel K., and Wiese S. Signalling molecules essential for neuronal survival and differentiation. Biochem Soc Trans 34 (2006) 1287-1290
22. Wang X., Gocek E., Liu C.G., and Studzinski G.P. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 8 5 (2009) 736-741 Epub 2009 Mar 18
23. Wang Q., Harrison J.S., Uskokovic M., Kutner A., and Studzinski G.P. Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia 19 (2005) 1812-1817
24. Campbell M.J., and Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin Ther Targets 10 (2006) 735-748
25. Wang X., and Studzinski G.P. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem 80 (2001) 471-482
26. Studzinski G.P., Garay E., Patel R., Zhang J., and Wang X. Vitamin D receptor signaling of monocytic differentiation in human leukemia cells: role of MAPK pathways in transcription factor activation. Curr Top Med Chem 6 (2006) 1267-1271
27. Wang Q., Salman H., Danilenko M., and Studzinski G.P. Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol 204 (2005) 964-974
28. Garay E., Donnelly R., Wang X., and Studzinski G.P. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor. J Cell Physiol 213 (2007) 816-825
29. Wang X., and Studzinski G.P. The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3. Cancer Res 66 (2006) 4402-4409
30. Studzinski G.P., Reddy K.B., Hill H.Z., and Bhandal A.K. Potentiation of 1-beta-d-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates. Cancer Res 51 (1991) 3451-3455
31. Wajchmann H.J., Rathod B., Song S., Xu H., Wang X., Uskokovic M.R., et al. Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3. Exp Cell Res 224 (1996) 312-322
32. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19 (1991) 2499
33. Marcinkowska E., Garay E., Gocek E., Chrobak A., Wang X., and Studzinski G.P. Regulation of C/EBP beta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res 312 (2006) 2054-2065
34. Lopez-Bergami P., Habelhah H., Bhoumik A., Zhang W., Wang L.H., and Ronai Z. RACK1 mediates activation of JNK by protein kinase C. Mol Cell 19 (2005) 309-320
35. Liu J., Minemoto Y., and Lin A. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24 (2004) 10844-10856
36. Sabapathy K., Hochedlinger K., Nam S.Y., Bauer A., Karin M., and Wagner E.F. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15 (2004) 713-725
37. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15 (1996) 2760-2770
38. Zhong S., Fromm J., and Johnson D.L. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Mol Cell Biol 27 (2007) 54-64
39. Hochedlinger K., Wagner E.F., and Sabapathy K. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21 (2002) 2441-2445
40. Sabapathy K., and Wagner E.F. JNK2: a negative regulator of cellular proliferation. Cell Cycle 3 (2004) 1520-1523
41. Jaeschke A., Karasarides M., Ventura J.J., Ehrhardt A., Zhang C., Flavell R.A., et al. JNK2 is a positive regulator of the cJun transcription factor. Mol Cell 23 (2006) 899-911